Back to Search
Start Over
Activation of AMPK in human fetal membranes alleviates infection-induced expression of pro-inflammatory and pro-labour mediators.
- Source :
-
Placenta [Placenta] 2015 Apr; Vol. 36 (4), pp. 454-62. Date of Electronic Publication: 2015 Jan 26. - Publication Year :
- 2015
-
Abstract
- Introduction: In non-gestational tissues, the activation of adenosine monophosphate (AMP)-activated kinase (AMPK) is associated with potent anti-inflammatory actions. Infection and/or inflammation, by stimulating pro-inflammatory cytokines and matrix metalloproteinase (MMP)-9, play a central role in the rupture of fetal membranes. However, no studies have examined the role of AMPK in human labour.<br />Methods: Fetal membranes, from term and preterm, were obtained from non-labouring and labouring women, and after preterm pre-labour rupture of membranes (PPROM). AMPK activity was assessed by Western blotting of phosphorylated AMPK expression. To determine the effect of AMPK activators on pro-inflammatory cytokines, fetal membranes were pre-treated with AMPK activators then stimulated with bacterial products LPS and flagellin or viral dsDNA analogue poly(I:C). Primary amnion cells were used to determine the effect of AMPK activators on IL-1β-stimulated MMP-9 expression.<br />Results: AMPK activity was decreased with term labour. There was no effect of preterm labour. AMPK activity was also decreased in preterm fetal membranes, in the absence of labour, with PROM compared to intact membranes. AMPK activators AICAR, phenformin and A769662 significantly decreased IL-6 and IL-8 stimulated by LPS, flagellin and poly(I:C). Primary amnion cells treated with AMPK activators significantly decreased IL-1β-induced MMP-9 expression.<br />Discussion: The decrease in AMPK activity in fetal membranes after spontaneous term labour and PPROM indicates an anti-inflammatory role for AMPK in human labour and delivery. The use of AMPK activators as possible therapeutics for threatened preterm labour would be an exciting future avenue of research.<br /> (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Subjects :
- Adult
Cells, Cultured
Chorioamnionitis drug therapy
Chorioamnionitis immunology
Chorioamnionitis pathology
Enzyme Activation drug effects
Enzyme Activators pharmacology
Extraembryonic Membranes drug effects
Extraembryonic Membranes immunology
Extraembryonic Membranes pathology
Female
Fetal Membranes, Premature Rupture drug therapy
Fetal Membranes, Premature Rupture immunology
Fetal Membranes, Premature Rupture pathology
Flagellin toxicity
Humans
Labor, Obstetric immunology
Labor, Obstetric metabolism
Ligands
Lipopolysaccharides toxicity
Obstetric Labor, Premature drug therapy
Obstetric Labor, Premature immunology
Obstetric Labor, Premature pathology
Phosphorylation drug effects
Pregnancy
Protein Processing, Post-Translational drug effects
Tissue Culture Techniques
Toll-Like Receptors agonists
Toll-Like Receptors metabolism
AMP-Activated Protein Kinases metabolism
Chorioamnionitis metabolism
Extraembryonic Membranes metabolism
Fetal Membranes, Premature Rupture metabolism
Inflammation Mediators metabolism
Obstetric Labor, Premature metabolism
Placentation
Subjects
Details
- Language :
- English
- ISSN :
- 1532-3102
- Volume :
- 36
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Placenta
- Publication Type :
- Academic Journal
- Accession number :
- 25659498
- Full Text :
- https://doi.org/10.1016/j.placenta.2015.01.007